Liver X receptors as potential targets for cancer therapeutics

Xiaoli Ju1, Pan Huang1, Miao Chen1,2

  • 1Department of Pathology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.

Oncology Letters
|December 19, 2017
PubMed

Insights

Liver X receptors (LXRs) regulate cholesterol and immunity. Emerging research suggests LXRs are promising therapeutic targets for various cancers, offering new avenues for clinical treatment.

Area of Science:

  • Molecular biology
  • Endocrinology
  • Oncology

Background:

  • Liver X receptors (LXRs) are nuclear receptors involved in cholesterol transport and immune responses.
  • Synthetic LXR ligands are utilized for treating metabolic and cardiovascular diseases.
  • Emerging evidence implicates LXRs in the pathogenesis of various cancers.

Purpose of the Study:

  • To review current knowledge on LXR ligands and their mechanisms.
  • To summarize the role of LXRs in different cancer types.
  • To evaluate the potential of LXRs as cancer therapeutic targets.

Main Methods:

  • Literature review of studies on LXR ligands and their effects in cancer.
  • Analysis of the mechanisms of action of LXRs in cancer.
  • Synthesis of data on clinical applications of LXR-targeting therapies.

Main Results:

  • LXR ligands exhibit diverse mechanisms of action.
  • LXRs play significant roles in the development and progression of multiple cancer types.
  • Preclinical data suggest potential for LXR-based cancer treatments.

Conclusions:

  • LXRs are implicated in cancer and represent potential therapeutic targets.
  • Further research into LXR modulation could lead to novel cancer therapies.
  • Clinical translation of LXR-targeting strategies warrants investigation.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.6K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K